The U.S. Food and Drug Administration approved Foundayo (orforglipron), Eli Lilly and Company's (NYSE: LLY) oral weight loss medication for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE